Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Biochim Biophys Acta. 2010 Oct 21;1808(1):498–507. doi: 10.1016/j.bbamem.2010.10.011

Table 1.

Secondary structure analysis of [113-122]apoJ in buffer and in the presence of DPC (lipid to peptide molar ratio, 125:1) and KOdiA-PC (lipid to peptide molar ratio, 25:1).

CDPro
SELCON3
H(r) H(d) S(r) S(d) Trn Unrd RMSD
[113-122]apoJ:Buffer 0.058 0.129 0.068 0.07 0.246 0.401 1.956
[113-122]apoJ:DPC (10 mM) 0.752 0.101 0.017 0.04 0.035 0.04 2.37
[113-122]apoJ:KOdiA-PC (2 mM) 0.124 0.119 0.156 0.098 0.228 0.306 0.337
Continll
[113-122]apoJ:Buffer 0.048 0.141 0.058 0.08 0.268 0.399 0.179
[113-122]apoJ:DPC (10 mM) 0.69 0.271 0 0 0.004 0.031 0.408
[113-122]apoJ:KOdiA-PC (2 mM) 0.162 0.173 0.007 0.044 0.271 0.343 0.237
CDSSTR
[113-122]apoJ:Buffer 0.074 0.135 0.133 0.08 0.253 0.299 0.467
[113-122]apoJ:DPC (10 mM) 0.585 0.19 0.034 0.03 0.043 0.108 0.676
[113-122]apoJ:KOdiA-PC (2 mM) 0.313 0.139 0.124 0.0085 0.128 0.214 0.595
K2D
Alpha Helix Beta Strand
[113-122]apoJ:Buffer 0.081 0.241
[113-122]apoJ:DPC (10 mM) 0.849 0.006
[113-122]apoJ:KOdiA-PC (2 mM) 0.105 0.291

H(r), regular helix; H(d), distorted helix; S(r), regular sheet; S(d), distorted sheet; Trn, turn; Unrd, unordered; RMSD, root mean square deviation between the calculated and experimental CD spectra.